Sareum Share Price | |
---|---|
Price | 205.00 |
Bid | 200.00 |
Ask | 210.00 |
Change | 2.50 (1.23%) |
Volume | 43,082 |
Open | 202.50 |
High | 205.00 |
Low | 200.00 |
Prev. Close | 205.00 |
Currency | GBX |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 68m |
Market Capitalisation | £140m |
Market Size | 2,000 |
52 Week High | 337.50 |
52 Week High Date | 13-Apr-2022 |
52 Week Low | 3.10 |
52 Week Low Date | 15-Feb-2022 |
# Trades | 34 |
---|---|
Vol. Sold | 26,984 |
Sold Value | £54,939.59 |
Vol. Bought | 16,098 |
Bought Value | £33,132.02 |
PE Ratio | -82.00 |
Earnings | -2.50 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
01-Jul-22 | 16:24:39 | 206.90 | 289 | Buy* | 200.00 | 210.00 | 597.94 | O Ordinary |
01-Jul-22 | 16:21:30 | 204.16 | 100 | Sell* | 200.00 | 210.00 | 204.16 | O Ordinary |
01-Jul-22 | 16:19:19 | 206.00 | 485 | Buy* | 200.00 | 210.00 | 999.10 | O Ordinary |
01-Jul-22 | 16:13:10 | 205.99 | 1,441 | Buy* | 200.00 | 210.00 | 2,968 | O Ordinary |
01-Jul-22 | 16:06:26 | 204.15 | 300 | Sell* | 200.00 | 210.00 | 612.45 | O Ordinary |
01-Jul-22 | 15:55:56 | 205.99 | 482 | Buy* | 200.00 | 210.00 | 992.87 | O Ordinary |
01-Jul-22 | 15:44:20 | 204.11 | 1,500 | Sell* | 200.00 | 210.00 | 3,062 | O Ordinary |
01-Jul-22 | 15:10:49 | 204.11 | 200 | Sell* | 200.00 | 210.00 | 408.22 | O Ordinary |
01-Jul-22 | 14:52:25 | 206.00 | 238 | Buy* | 200.00 | 210.00 | 490.28 | O Ordinary |
01-Jul-22 | 14:50:13 | 205.90 | 1,038 | Buy* | 200.00 | 210.00 | 2,137 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
23-Nov-21 | 23-Nov-21 | Buy | Stephen Parker held the position of Non-Executive Chairman at the time of this trade. Stephen Parker | 3.60 | GBX | 277,777 | 4,184,440 |
20-Oct-20 | 19-Oct-20 | Sell | Timothy J Mitchell held the position of CEO at the time of this trade. Timothy J Mitchell | 1.14 | GBX | 3,076,923 | 50,476,073 |
20-Oct-20 | 19-Oct-20 | Exercise of option | Timothy J Mitchell held the position of CEO at the time of this trade. Timothy J Mitchell | 0.26 | GBX | 6,153,846 | 53,552,996 |
01-Jul-20 | 30-Jun-20 | Buy | Stephen Parker held the position of Non-Executive Chairman at the time of this trade. Stephen Parker | 0.60 | GBX | 2,160,686 | 3,906,663 |
01-Jul-20 | 30-Jun-20 | Buy | Clive Birch held the position of Non-Executive Director at the time of this trade. Clive Birch | 0.60 | GBX | 751,394 | 2,001,394 |
Sareum’s small molecule drug discovery expertise builds value by developing drug candidates, focused on cancer and autoimmune disease, for licencing to pharmaceutical and biotechnology companies.